Could an Outbreak Deployment Reshape Island Pharma?
Highlights Island Pharmaceuticals has moved to deploy its antiviral candidate to help treat patients caught in an Ebola outbreak in Uganda. The humanitarian deployment offers a rare real-world setting to observe the compound outside a formal trial. The news lands amid a broad rebound in Australian healthcare shares from recent lows. Island Pharmaceuticals (ASX:ILA), the Sydney-based clinical-stage developer focused on repurposing antiviral compounds against dangerous ...


